Nuvation Bio completes full greenshoe, raising $287.5M in convertible notes

Nuvation Bio Inc.

Underwriters exercised full over-allotment for additional $37.5M of 0.75% Convertible Senior Notes due 2032.
Total aggregate principal amount of Notes sold: $287.5M; estimated net proceeds ~$277.6M.
Net proceeds used to pay $2.2M for additional capped call transactions; remainder for general corporate purposes.
Capped call transactions have cap price of $10.4580 per share, an 80% premium over June 25 closing price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.